TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
NCT05862324
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Solid Tumor
Interventions
BIOLOGICAL:
TAC01-CLDN18.2
Sponsor
Triumvira Immunologics, Inc.